The Middle East Empty Capsules Market was valued at $57.4 Million in 2025 and projected to reach to $68.5 Million by 2030, representing a compound annual growth rate of 3.6%. The Middle East empty capsules market is poised for steady expansion driven by increasing healthcare investments and the region's growing pharmaceutical manufacturing base.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The Middle East empty capsules market is valued at $57.4 million in 2025, with steady growth projected through 2030 as pharmaceutical manufacturers expand operations across the region.
Expanding at a CAGR of 3.6% from 2025 to 2030, the Middle East market demonstrates moderate but consistent growth, reaching $68.5 million by forecast end, outpacing some mature markets.
Rising healthcare expenditure and regulatory support in Middle Eastern countries are driving increased adoption of empty capsules for pharmaceutical and nutraceutical applications, particularly in customized dosage forms.
Saudi Arabia and UAE lead the region's market, supported by advanced healthcare infrastructure, growing pharmaceutical manufacturing capacity, and increasing demand for personalized medicine solutions.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SUSTAINED-RELEASE CAPSULES (Functionality) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 5.6% from 2025 to 2030 |
| Largest Segment | IMMEDIATE-RELEASE CAPSULES (Functionality) |
| Market Size Base Year (Billions) | ~USD 3.19 (2025) |
| Revenue Forecast (Billions) | ~USD 4.19 (2030) |
| Segments Covered | Type, Raw Material, Functionality, Size, Therapeutic Application, End User |
6 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| PATHEON INC | Netherlands | Private Company | Drug product services (finished dosage manufacturing, packaging, lifecycle management),Pharmaceutical development services (formulation, clinical trial supply),Drug substance services (API and biologics substance), |
| ALLERGAN PLC | Ireland | Private Company | Medical aesthetics and dermatology,Eye care,Neuroscience and CNS, |
| HELM AG | Germany | Private Company | Basic Chemicals, Acids and Lyes,Plastics and Polyurethanes,Crop Protection and Fertilizers, |
| SUNIL HEALTHCARE LIMITED | India | Public Company | Standard empty hard gelatin capsules (incl. BSE/TSE free, pearl, natural color),Functional and specialty capsules (liquid-fill, preservative-free, stick-free, flavored, SLS-free, non-AZO),HPMC/vegetable capsules, |
| NATURAL CAPSULES LIMITED | India | Public Company | Standard hard gelatin capsule shells,Vegetarian and cellulose-based capsule shells,Enteric, fast-release, and functional capsules, |
| ANHUI HUANGSHAN CAPSULE CO., LTD. | China | Public Company | Vacant gelatin capsules (standard),Enteric-coated / entersoluble gelatin capsules,Vegetable capsules (HPMC, pullulan, vegetable entersoluble), |
Patheon Inc. is a Netherlands-based private company with 9,100 employees operating in the pharmaceutical and contract manufacturing sector.
Allergan PLC is an Ireland-incorporated private company founded in 1983 with 17,400 employees, operating in the pharmaceutical and specialty healthcare industry.
Helm AG is a Germany-based private company founded in 1900 with 1,430 employees, operating in the pharmaceutical and chemical distribution industry.
Sunil Healthcare Limited is an India-based public company founded in 1973 with 161 employees operating in the pharmaceutical sector.
Natural Capsules Limited is an India-based public company founded in 1993 with 615 employees operating in the pharmaceutical capsule manufacturing industry.
Anhui Huangshan Capsule Co., Ltd. is a China-based public company founded in 1989 with 639 employees operating in the pharmaceutical capsule manufacturing industry.
| Country | 2025 size (native) |
|---|---|
| Saudi Arabia | USD 14.9 Million |
| UAE | USD 7.7 Million |
| Rest Of GCC Countries | USD 6.9 Million |
| Rest Of Middle East | USD 1.15 Million |
The Middle East empty capsules market is valued at $57.4 million in 2025.
The Middle East empty capsules market is projected to reach $68.5 million by 2030.
The Middle East empty capsules market is expected to grow at a CAGR of 3.6% from 2025 to 2030.
Key drivers in the Middle East include rising healthcare expenditure, growing pharmaceutical manufacturing, increasing demand for customized dosage forms, and the shift toward plant-based capsule alternatives.
Plant-based and vegetarian empty capsules are gaining significant momentum in the Middle East due to evolving consumer preferences and stricter regulatory requirements.
This research extensively utilized secondary sources, directories, and databases to gather valuable information for analyzing the global empty capsules market. In-depth interviews were conducted with various primary respondents, including key industry players, subject-matter experts (SMEs), C-level executives, and industry consultants, to obtain and verify important qualitative and quantitative data and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to determine the final market size.
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the Empty capsules market. The secondary sources used for this study includes European Federation of Pharmaceutical Industries and Associations (EFPIA), United States Food and Drug Administration (US FDA), Central Drugs Standard Control Organisation (CDSCO), Drugs Technical Advisory Board (DTAB), Pharmaceutical Research and Manufacturers of America (PhRMA), Indian Pharmaceutical Association (IPA), National Institutes of Health (NIH), World Health Organization (WHO), among others. Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
After an initial assessment of the global empty capsules market landscape through secondary research, comprehensive primary research was conducted. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from the pharmaceutical, nutraceutical, and cosmetic industries, as well as research laboratories. Additionally, interviews were held with key supply-side participants, such as C-suite and senior executives, product managers, and marketing and sales leaders from leading empty capsules manufacturers, distributors, and channel partners. The research covered six major regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. About 70% of the primary interviews were with supply-side participants, while 30% involved demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and phone discussions to thoroughly understand market dynamics.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Both bottom-up and top-down approaches were used to estimate and validate the total size of the empty capsules market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
A list of the major global players operating in the empty capsules market was generated.
The revenues generated from their empty capsules product have been determined through annual reports and secondary sources (including paid databases)
The products were mapped according to the segments of the market. Percentage shares and splits were determined based on the revenue contributed to each segment. This was verified using secondary sources and by industry experts.
The combined revenue share of the players was estimated and then added up to 100% to derive the global empty capsules market.
All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.

After determining the market size through the estimation process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown methods were used whenever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
A capsule is a form of solid oral dosage that consists of a container, usually made of gelatin or HPMC material, filled with a medicinal substance. Empty capsules are hard shells of various shapes, typically designed to hold a single dose of active ingredients. At the time of sale, these capsules are not filled with any pharmaceutical or nutraceutical ingredients. They are made in two halves: a smaller-diameter “body” that is filled and sealed with a larger-diameter “cap”.
Full forecast, segment splits, and company analysis for all Empty Capsules Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report